Evaluating Elacestrant in the Management of ER-Positive, HER2-Negative Advanced Breast Cancer: Evidence to Date

Varella, L; Cristofanilli, M

Varella, L (通讯作者),Weill Cornell Med, Internal Med Dept, Div Med Oncol, New York, NY 10065 USA.

ONCOTARGETS AND THERAPY, 2023; 16 (): 189

Abstract

Breast cancer remains the second leading cause of cancer mortality in women. Endocrine therapy is the backbone treatment for hormone receptor (HR)-pos......

Full Text Link